These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 8431012

  • 1. Susceptibilities of beta-lactamase-producing and -nonproducing ampicillin-resistant strains of Haemophilus influenzae to ceftibuten, cefaclor, cefuroxime, cefixime, cefotaxime, and amoxicillin-clavulanic acid.
    Barry AL, Fuchs PC, Pfaller MA.
    Antimicrob Agents Chemother; 1993 Jan; 37(1):14-8. PubMed ID: 8431012
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.
    Fuchs PC, Barry AL.
    J Clin Microbiol; 1994 Nov; 32(11):2846-50. PubMed ID: 7852584
    [Abstract] [Full Text] [Related]

  • 4. Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
    Perea EJ, Garcia Iglesias MC.
    J Antimicrob Chemother; 1994 Jul; 34(1):161-4. PubMed ID: 7961203
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
    Liljequist BO, Gezelius L.
    Eur J Clin Microbiol; 1986 Dec; 5(6):615-21. PubMed ID: 3492374
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of BAY v 3522, a new oral cephalosporin tested against Haemophilus influenzae and Branhamella catarrhalis.
    Doern GV, Tubert TA.
    Diagn Microbiol Infect Dis; 1990 Dec; 13(4):349-52. PubMed ID: 2127558
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [In vitro effect of cefixime against Haemophilus influenzae].
    Dabernat H, Delmas C.
    Presse Med; 1989 Oct 11; 18(32):1551-2. PubMed ID: 2530529
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
    Jacobs MR, Bajaksouzian S.
    Diagn Microbiol Infect Dis; 1997 Jul 11; 28(3):105-12. PubMed ID: 9294699
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
    Delmée M, Carpentier M, Glupczynski Y, Gordts B, Magerman K, Simon A, Surmont I, Van de Vyvere M, Van Landuyt H, Van Nimmen L, Van Noyen R.
    Acta Clin Belg; 1996 Jul 11; 51(4):237-43. PubMed ID: 8858889
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
    Tremblay LD, L'Ecuyer J, Provencher P, Bergeron MG.
    CMAJ; 1990 Nov 01; 143(9):895-901. PubMed ID: 2224717
    [Abstract] [Full Text] [Related]

  • 13. Genetic diversity of the ftsI gene in β-lactamase-nonproducing ampicillin-resistant and β-lactamase-producing amoxicillin-/clavulanic acid-resistant nasopharyngeal Haemophilus influenzae strains isolated from children in South Korea.
    Park C, Kim KH, Shin NY, Byun JH, Kwon EY, Lee JW, Kwon HJ, Choi EY, Lee DG, Sohn WY, Kang JH.
    Microb Drug Resist; 2013 Jun 01; 19(3):224-30. PubMed ID: 23308379
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
    Zanchi A, Mencarelli M, Sansoni A, Rossolini A, Cellesi C.
    Eur J Epidemiol; 1994 Dec 01; 10(6):699-702. PubMed ID: 7672050
    [Abstract] [Full Text] [Related]

  • 15. Increasing Prevalence of Group III Penicillin-Binding Protein 3 Mutations Conferring High-Level Resistance to Beta-Lactams Among Nontypeable Haemophilus influenzae Isolates from Children in Korea.
    Han MS, Jung HJ, Lee HJ, Choi EH.
    Microb Drug Resist; 2019 May 01; 25(4):567-576. PubMed ID: 30484742
    [Abstract] [Full Text] [Related]

  • 16. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
    García-Cobos S, Campos J, Lázaro E, Román F, Cercenado E, García-Rey C, Pérez-Vázquez M, Oteo J, de Abajo F.
    Antimicrob Agents Chemother; 2007 Jul 01; 51(7):2564-73. PubMed ID: 17470649
    [Abstract] [Full Text] [Related]

  • 17. [Comparison of the in vitro activity of amoxycillin + clavulanic acid and ampicillin + sulbactam combinations against 50 Haemophilus influenzae strains producing beta lactamase].
    Moittie D, Simonet M, Veron M.
    Pathol Biol (Paris); 1989 May 01; 37(5):390-3. PubMed ID: 2789362
    [Abstract] [Full Text] [Related]

  • 18. influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.
    Torrico M, Aguilar L, González N, Giménez MJ, Echeverría O, Cafini F, Sevillano D, Alou L, Coronel P, Prieto J.
    Antimicrob Agents Chemother; 2007 Oct 01; 51(10):3699-706. PubMed ID: 17664320
    [Abstract] [Full Text] [Related]

  • 19. Problems with current recommendations for susceptibility testing of Haemophilus influenzae.
    Mendelman PM, Wiley EA, Stull TL, Clausen C, Chaffin DO, Onay O.
    Antimicrob Agents Chemother; 1990 Aug 01; 34(8):1480-4. PubMed ID: 2221855
    [Abstract] [Full Text] [Related]

  • 20. [Study of susceptibility of Haemophilus influenzae to beta-lactams by using HTM gelose (Haemophilus test medium)].
    Dabernat H, Seguy M, Delmas C.
    Pathol Biol (Paris); 1993 Sep 01; 41(7):589-95. PubMed ID: 8255610
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.